Skip to main content

Advertisement

SpringerLink
Log in

Neuropsychiatric syndromes associated with multiple sclerosis

  • Published:
Journal of Neurology Aims and scope Submit manuscript

An Erratum to this article was published on 01 February 2008

Abstract

Multiple sclerosis is associated with diverse behavioral changes. Rates of major depression approach 50% over the course of patients' lives, rates of bipolar disorder and psychosis are twice as common when compared to rates in the general population and pseudobulbar affect will afflict one in ten patients. However, these disorders often respond well to pharmacologic treatment and in the case of major depression, some forms of psychotherapy too. This article summarizes these mental state changes, their pathogenesis and treatment. Correct diagnosis and treatment can substantially improve the quality of life for MS patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Asghar A, Taber KH, Hurley RA, Hayman LA (2004) Pure neuropsychiatric presentation of multiple sclerosis. Am J Psychiatry 161:226–231

    Article  Google Scholar 

  2. Bakshi R, Czarnecki D, Shaikh ZA, Priore RL, Janardhan V et al. (2000) Brain MRI lesions and atrophy are related to depression in multiple sclerosis. NeuroReport 11:1153–1158

    Article  PubMed  CAS  Google Scholar 

  3. Beck AT, Steer RA, Brown GK (2000) BDI-Fast Screen for Medical Patients Manual. The Psychological Corporation, San Antonio, Tx

  4. Benedict RH, Fishman I, McClellan MM, Bakshi R,Weinstock-Guttman B (2003) Validity of the Beck Depression Inventory-Fast Screen in multiple sclerosis. Multi Scler 9:393–396

    Article  CAS  Google Scholar 

  5. Davison K, Bagley CR (1969) Schizophrenia- like psychoses associated with organic disorders off the central nervous system. A review of the literature. In: Herrington RN (ed) Current problems in neuropsychiatry. Hedley, Ashford, Kent, pp 113–184

  6. Feinstein A (2000) Multiple sclerosis, depression and disease modifying drugs. Mult Scler 6:343–348

    PubMed  CAS  Google Scholar 

  7. Feinstein A (2002) An examination of suicidal intent in patients with multiple sclerosis. Neurology 59:674–678

    PubMed  Google Scholar 

  8. Feinstein A, du Boulay G, Ron MA (1992) Psychotic illness in multiple sclerosis.A clinical and magnetic resonance imaging study. Br J Psychiatry 161:680–685

    Article  PubMed  CAS  Google Scholar 

  9. Feinstein A, Feinstein KJ, Gray T, O'Connor P (1997) The prevalence and neurobehavioral correlates of pathological laughing and crying in multiple sclerosis. Arch Neurol 54:1116–1121

    PubMed  CAS  Google Scholar 

  10. Feinstein A, O'Connor P, Gray T, Feinstein KJ (1999) The pathogenesis of pathological laughing and crying in multiple sclerosis: a role for the prefrontal cortex? Mult Scler 5:69–73

    PubMed  CAS  Google Scholar 

  11. Feinstein A, Roy P, Lobaugh N, Feinstein KJ, O'Connor P (2004) Structural brain abnormalities in multiple sclerosis patients with major depression. Neurology 62:586–590

    PubMed  CAS  Google Scholar 

  12. Flax JW, Gray J, Herbert J (1991) Effects of fluoxetine on patients with multiple sclerosis. Am J Psychiatry 148:1603

    PubMed  CAS  Google Scholar 

  13. Joffe RT, Lippert GP, Gray TA, Sawa G, Horvath Z (1987) Personal and family history of affective disorder. J Affect Disord 12:63–65

    Article  PubMed  CAS  Google Scholar 

  14. Lynch SG. Kroencke DC, Denney DR (2001) The relationship between disability and depression in multiple sclerosis: the role of uncertainty, coping and hope. Mult Scler 7:411–416

    PubMed  CAS  Google Scholar 

  15. Minden SL, Schiffer RB (1990) Affective disorders in multiple sclerosis: Review and recommendations for clinical research. Arch Neurol 47:98–104

    PubMed  CAS  Google Scholar 

  16. Mohr DC, Boudewyn AC, Goodkin D, Bostrom A, Epstein L (2001) Comparative outcomes for individual cognitivebehavior therapy, supportive-expressive group therapy, and sertraline for the treatment of depression in multiple sclerosis. J Consult Clin Psychol 69:942–949

    Article  PubMed  CAS  Google Scholar 

  17. Panitch HS, Thisted RA, Smith RA, Wynn DR,Wymer JP et al. (2006) Randomized, controlled trial of dextromethorphan/quinidine for pseudobulbar affect in multiple sclerosis. Ann Neurol 59:780–787

    Article  PubMed  CAS  Google Scholar 

  18. Patten SB, Beck CA, Williams JVA, Barbui C, Metz LM (2003) Major depression in multiple sclerosis. A population-based perspective. Neurology 61:1524–1527

    PubMed  CAS  Google Scholar 

  19. Patten SB, Svenson LW, Metz LM (2005) Psychotic disorders in MS: Population-based evidence of an association. Neurology 65:1123–1125

    Article  PubMed  Google Scholar 

  20. Pujol J, Bello J, Deus J, Marti-Vilalta JL, Capdevila A (1997) Lesions in the left arcuate fasciculus region and depressive symptoms in multiple sclerosis. Neurology 49:1105–1110

    PubMed  CAS  Google Scholar 

  21. Rabins PV (1990) Euphoria in multiple sclerosis. In: Rao SM (ed) Neurobehavioral aspects of multiple sclerosis. Oxford University Press, New York, pp 180–185

  22. Sadovnik AD, Eisen RN, Ebers GC, Paty DW (1991) Cause of death in patients attending multiple sclerosis clinics. Neurology 41:1193–1196

    Google Scholar 

  23. Schiffer RB, Herndon RM, Rudick RA (1983) Treatment of pathologic laughter and weeping with amitriptyline. NEJM 312:1480–1482

    Google Scholar 

  24. Schiffer RB, Wineman NM (1990) Antidepressant pharmacotherapy of depression associated with multiple sclerosis. Am J Psychiatry 147:1493–1497

    PubMed  CAS  Google Scholar 

  25. Schubert RSB, Foliart RH (1993) Increased depression in multiple sclerosis: A meta-analysis. Psychosomatics 34:124–130

    PubMed  CAS  Google Scholar 

  26. Seliger GM, Hornstein A, Flax J, Herbert J, Schroder K (1992) Fluoxetine improves emotional incontinence. Brain Inj 6:267–270

    PubMed  CAS  Google Scholar 

  27. Stenager EN, Stenager E (1992) Suicide and patients with neurologic diseases. Methodologic problems. Arch Neurol 49:1296–1303

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Dept. of Psychiatry, University of Toronto, Sunnybrook Health Sciences Centre, 2075 Bayview Avenue, Toronto, Ontario, Canada M4N 3M5

    Anthony Feinstein MPhil, PhD, FRCPC

Authors
  1. Anthony Feinstein MPhil, PhD, FRCPC
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Anthony Feinstein MPhil, PhD, FRCPC.

Additional information

An erratum to this article is available at http://dx.doi.org/10.1007/s00415-008-0901-z.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Feinstein, A. Neuropsychiatric syndromes associated with multiple sclerosis. J Neurol 254 (Suppl 2), II73–II76 (2007). https://doi.org/10.1007/s00415-007-2017-2

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-007-2017-2

Key words

Search

Navigation